Peer reviewed Feature Articles
Women’s health
Premature ovarian insufficiency: recommendations from the new guidelines
Premature ovarian insufficiency should be considered in women younger than 40 years of age with four months or more of menstrual disturbance. It is associated with an increased risk of multimorbidity, such as osteoporosis, cardiovascular disease, infertility and decreased survival. Personalised hormone therapy is the mainstay of treatment and should be initiated promptly and continued until at least the usual age of menopause to minimise the risk of long-term sequelae.
May 2025
Thyroid gland disorders
Differentiating Hashimoto’s thyroiditis and Graves’ disease: a practical guide
May 2025
Peer reviewed Regular Series
Perspectives
Treating vasomotor symptoms during menopause
Advertisement
Physician-authored summaries and commentary on the most important medical research, provided by the NEJM Group, a division of the Massachusetts Medical Society.
© Massachusetts Medical Society
How safe is metformin in stage 4 chronic kidney disease?
Am J Kidney Dis
Advertisement